IndraLab

Statements

Rosiglitazone inhibits JUN. 1 / 1

| 1

reach

"Rosiglitazone, a peroxisome proliferator activated receptor-gamma, inhibits the Jun NH (2)-terminal kinase and activating protein 1 pathway and protects the heart from ischemia and reperfusion injury."

11978649

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Rosiglitazone inhibits JUN. 1 / 1

INDRA sources:

Databases

Reading